PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia

PHASE4CompletedINTERVENTIONAL

Enrollment

484

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Breast Cancer

Interventions

DRUG

PEG-rhG-CSF

All Listed Sponsors

lead

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

INDUSTRY

NCT02805205 - PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia | Biotech Hunter | Biotech Hunter